Pfizer had just acquired Wyeth Corporation and was seeking a rapid transition of that company’s patent, trademark, and litigation documents. Adding to the challenge was that the document conversion needed to take place on site at Pfizer, eliminating the need for any of Pfizer’s documents to be moved from their existing file room or for their data to leave their network. This option assured the highest level of data security for this mission-critical conversion.
KeyMark used a creative balance of technology and imaging experience to achieve Pfizer’s goal. By leveraging KeyMark’s staff and equipment, the project team was able to create a high volume on-site production conversion platform that met the needs of the client. A key requirement of the conversion was having indexed document images available for use by the intellectual property organization within a couple of days of scanning.
In less than six months, imaging professionals successfully scanned eight million secure documents and converted them to searchable electronic files.
Utilizing KeyMark’s imaging experience and technology allowed Pfizer to seamlessly and securely transition eight million documents from a business acquisition. The process was done quickly, efficiently, and under budget.
“The scope and speed of this operation was simply amazing. We went from bidding the project to start-up in just four weeks. KeyMark completed the initiative on time and under budget, despite several roadblocks we threw at them along the way!” -Carmen Lantigua, Pfizer Director – IP Global Services
New York-based Pfizer is a diversified, global healthcare company dedicated to the discovery, development, and manufacturing of medicines, vaccines, and nutritional products for people and animals. Pfizer works across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.